Stay updated on Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page update is limited to metadata/UI changes: the revision label was updated from v3.0.0 to v3.0.1 and a 'Back to Top' link was added; there are no changes to core content, pricing, stock availability, or scheduling.
    Difference
    0.1%
    Check dated 2025-09-09T15:19:16.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new drug information for Lazertinib and Amivantamab, as well as numerous location details across various countries. Additionally, the facility name has been included, while some previous location entries and drug information have been removed.
    Difference
    19%
    Check dated 2025-09-02T08:16:03.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The webpage has updated its date references, removing older dates from July 2025 and adding new dates in August 2025.
    Difference
    0.3%
    Check dated 2025-08-26T06:28:49.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.0%
    Check dated 2025-08-11T22:05:49.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.8 to version 2.16.11, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-08-04T19:31:50.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.16.8) and a new last update date (July 20, 2025), replacing the previous version (v2.16.6) and last update date (July 17, 2025).
    Difference
    0.7%
    Check dated 2025-07-28T15:29:48.000Z thumbnail image

Stay in the know with updates to Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.